Latest / Oakland News Today | 2 Min News | The Daily News Now!
Moderna’s mRNA Flu Vaccine Approved | Oakland News
Moderna just landed FDA approval for its groundbreaking mRNA flu vaccine, mFLUSIVA, designed for adults 50 and older—marking the first mRNA flu shot in the U.S. and a major leap for vaccine tech beyond COVID-19. After an initial rejection, Moderna pivoted by conducting a new study post-launch, convincing regulators to review—and ultimately approve—the vaccine. This winter, it’ll go head-to-head with the current high-dose flu shot for seniors, with results shaping future approvals. The mRNA platform’s speed and adaptability could revolutionize how we combat fast-evolving viruses, offering…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.